Attached files
| file | filename |
|---|---|
| EX-99.2 - EX-99.2 - Cardiogenesis Corp /CA | a54342exv99w2.htm |
| EX-99.1 - EX-99.1 - Cardiogenesis Corp /CA | a54342exv99w1.htm |
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): November 10, 2009
CARDIOGENESIS CORPORATION
(Exact name of registrant as specified in its charter)
| California | 000-28288 | 77-0223740 | ||
| (State or other jurisdiction of incorporation) |
(Commission File Number) | (IRS Employer Identification No.) |
11 Musick
Irvine, CA 92618
(Address of principal executive offices, including zip code)
Irvine, CA 92618
(Address of principal executive offices, including zip code)
Registrant’s telephone number, including area code: (949) 420-1800
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the
filing obligation of the registrant under any of the following provisions:
| o | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) | |
| o | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) | |
| o | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) | |
| o | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Item 2.02 Results of Operation and Financial Condition
On November 10, 2009, Cardiogenesis Corporation (the “Company”) issued a press release announcing
its financial results for the quarter ended September 30, 2009. The press release is furnished as
Exhibit 99.1 and is incorporated herein by reference.
Also on November 10, 2009, the Company held a conference call with analysts and investors to report
its financial results for the quarter ended September 30, 2009. The transcript of the conference
call is furnished as Exhibit 99.2 and is incorporated herein by reference.
The information in this Form 8-K, including Exhibits 99.1 and 99.2, are furnished pursuant to Item
2.02 and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of
1934, nor shall they be deemed incorporated by reference in any filing under the Securities Act of
1933, except as shall be expressly set forth by specific reference in such filing.
Item 9.01 Financial Statements and Exhibits
(d) Exhibits
| Exhibit Number | Description | |
99.1
|
Press release of Cardiogenesis Corporation dated November 10, 2009. | |
99.2
|
Conference Call Transcript dated November 10, 2009. |
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly
caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| CARDIOGENESIS CORPORATION (Registrant) |
||||
| Date: November 12, 2009 | By: | /s/ William Abbott | ||
| William Abbott, Chief Financial Officer and Secretary | ||||
Exhibit Index
| Exhibit Number | Description | |
99.1
|
Press release of Cardiogenesis Corporation dated November 10, 2009. | |
99.2
|
Conference Call Transcript dated November 10, 2009. |